Live Breaking News & Updates on Sodium Glucose Cotransporter 2 Inhibitors

Stay updated with breaking news from Sodium glucose cotransporter 2 inhibitors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Empagliflozin Fails to Reduce Events After Acute MI

Empagliflozin did not significantly reduce overall HF hospitalization or all-cause death in high-risk patients in EMPACT-MI but did reduce first and total hospitalizations. ....

New York , United States , James Januzzi , Deepak Bhatt , Valentin Fuster , Carine Hamo , Michelle Albert , Javed Butler , Baylor Scott White Research Institute , American College Of Cardiology , Grossman School Of Medicine , Leonh Charney Division Of Cardiology , Department Of Medicine , American College , Scientific Sessions , New England Journal , Baylor Scott , White Research Institute , Mount Sinai Heart , Icahn School , Mount Sinai Health System , New York City , Lancet Diabetes , Myocardial Infarction , Heart Failure , Sglt2 Inhibitors ,

SGLT2 Inhibitors Safe for HF in Congenital Heart Disease

SGLT2 inhibitors not only were safe in adult patients with congenital heart disease who develop heart failure but also were associated with reduced hospitalizations. ....

United States , University Medical Center , Anastasiad Egorova , Lukej Burchill , Journal Of The American College Cardiology , European Society Of Cardiology , Department Of Cardiovascular Medicine , Leiden University Medical Center , American College , European Society , Cardiovascular Medicine , Mayo Clinic , Heart Failure , Sglt2 Inhibitors , Odium Glucose Transporter 2 Inhibitors , Odium Glucose Co Transporter 2 Inhibitors , Sodium Glucose Cotransporter 2 Inhibitors , Diabetes Mellitus Type 2 , Iabetes Mellitus Type Ii , Type 2 Diabetes , Ype 2 Dm , Congenital Heart Disease , Adverse Effects , Side Effects , Patient Safety , Skin And Soft Tissue Infection ,

SGLT2 Inhibitors Reduce Kidney Stone Risk in Type 2 Diabetes

Patients with type 2 diabetes treated with SGLT2 inhibitors vs other common diabetes drugs show up to a 31% reduced risk of kidney stone development. ....

United States , Julie Paik , Division Of Pharmacoepidemiology , Division Of Renal Kidney Medicine At Brigham , Medscape Medical , Urinary Citrate , Diabetes Mellitus Type 2 , Iabetes Mellitus Type Ii , Type 2 Diabetes , Ype 2 Dm , Kidney Stones , Renal Calculus , Renal Calculi , Sglt2 Inhibitors , Odium Glucose Transporter 2 Inhibitors , Odium Glucose Co Transporter 2 Inhibitors , Sodium Glucose Cotransporter 2 Inhibitors , Renal Disease , Kidney Disease , Kidney Disorder , Renal Disorder , Renal Failure ,

SGLT2 Inhibitors Protective Against Retinopathy in T2D

SGLT2 inhibitors are known to reduce diabetic nephropathy risk in patients with type 2 diabetes, but can they also protect against diabetic retinopathy? ....

Fu Shun Yen , Diabetes Mellitus Type 2 , Iabetes Mellitus Type Ii , Type 2 Diabetes , Ype 2 Dm , Sglt2 Inhibitors , Odium Glucose Transporter 2 Inhibitors , Odium Glucose Co Transporter 2 Inhibitors , Sodium Glucose Cotransporter 2 Inhibitors , Microvascular Complications Of Diabetes , Retinal Disease , Diabetic Retinopathy , Sulfonylureas Sulphonylureas , Diabetic Nephropathy , Dpp 4 Inhibitors ,

SGLT2 Inhibitors Begin to Show Potential in Rheumatology

Sodium-glucose cotransporter-2 inhibitors are not approved to treat gout, lupus, or lupus nephritis, but clinicians are uncovering signs of benefits in these conditions. ....

United States , United Kingdom , Bristol Myers Squibb , Michelle Petri , April Jorge , Chio Yokose , Bernard Cheung , Johns Hopkins , Johns Hopkins University , Crystal Associated Disease Network , European Alliance Of Associations , American Society Of Health , University Of Maryland , Harvard Medical School , Research Hints At Gout , American College Of Rheumatology , National Kidney Foundation , University Of Hong Kong , Massachusetts General Hospital , Massachusetts General , Both Dr Jorge , Urate Levels , American College , Findings Are More , Harvard Medical , European Alliance ,